---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-112975"
form_type: "8-K"
ticker: "NXTC"
cik: "0001661059"
company_name: "NextCure, Inc."
filed_at: "2025-11-17T23:59:59+00:00"
generated_at: "2026-05-16T19:17:24.687814+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# NextCure closes $21.5M PIPE led by Ikarian, Squadron; extends cash runway into H1 2027

## Summary
- Gross proceeds of ~$21.5M from PIPE closed Nov 14, 2025; 708,428 shares at $8.52 and 1,815,049 pre-funded warrants at $8.519.
- Lead investors: Ikarian Capital, Squadron Capital Management, Affinity Healthcare Fund, Exome Asset Management; H.C. Wainwright placement agent.
- Cash runway extended into H1 2027, beyond planned H1 2026 POC data readouts for SIM0505 (CDH6 ADC) and LNCB74 (B7-H4 ADC).
- Registration rights agreement entered to file resale registration statement with SEC for the sold securities.
- Management believes existing cash, equivalents, and marketable securities sufficient to fund operations into first half of 2027.

## SEC filing metadata
- accession: 0001104659-25-112975
- form_type: 8-K
- ticker: NXTC
- cik: 0001661059
- company_name: NextCure, Inc.
- filed_at: 2025-11-17T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661059/000110465925112975/0001104659-25-112975-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661059/000110465925112975/nxtc-20251112x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-112975
- JSON: https://secwatch.observer/filing/0001104659-25-112975.json
- Plain text: https://secwatch.observer/filing/0001104659-25-112975.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.